Next Article in Journal
Expression of Potential Antibody–Drug Conjugate Targets in Cervical Cancer
Previous Article in Journal
Programmed Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor and Monitor of Response to Atezolizumab plus Bevacizumab Treatment in Patients with Hepatocellular Carcinoma
Previous Article in Special Issue
TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics
 
 
Review

Article Versions Notes

Cancers 2024, 16(9), 1786; https://doi.org/10.3390/cancers16091786
Action Date Notes Link
article xml file uploaded 6 May 2024 11:46 CEST Original file -
article xml uploaded. 6 May 2024 11:46 CEST Update -
article pdf uploaded. 6 May 2024 11:46 CEST Version of Record https://www.mdpi.com/2072-6694/16/9/1786/pdf-vor
article html file updated 6 May 2024 11:48 CEST Original file -
article xml file uploaded 7 May 2024 04:04 CEST Update -
article xml uploaded. 7 May 2024 04:04 CEST Update https://www.mdpi.com/2072-6694/16/9/1786/xml
article pdf uploaded. 7 May 2024 04:04 CEST Updated version of record https://www.mdpi.com/2072-6694/16/9/1786/pdf
article html file updated 7 May 2024 04:06 CEST Update https://www.mdpi.com/2072-6694/16/9/1786/html
Back to TopTop